Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Benton, S; Zhao, JF; Zhang, B; Bahrami, A; Barnhill, RL; Busam, K; Cerroni, L; Cook, MG; de la FouchardiUre, A; Elder, DE; Johansson, I; Landman, G; Lazar, A; LeBoit, P; Lowe, L; Massi, D; Duncan, LM; Messina, J; Mihic-Probst, D; Mihm, MC; Piepkorn, MW; Schmidt, B; Scolyer, RA; Shea, CR; Tetzlaff, MT; Tron, VA; Xu, XW; Yeh, IW; Yun, SJ; Zembowicz, A; Gerami, P.
Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms
AM J SURG PATHOL. 2021; 45(12): 1597-1605.
Doi: 10.1097/PAS.0000000000001753
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Cerroni Lorenzo
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Atypical Spitzoid melanocytic tumors are diagnostically challenging. Many studies have suggested various genomic markers to improve classification and prognostication. We aimed to assess whether next-generation sequencing studies using the Tempus xO assay assessing mutations in 1711 cancer-related genes and performing whole transcriptome mRNA sequencing for structural alterations could improve diagnostic agreement and accuracy in assessing neoplasms with Spitzoid histologic features. Twenty expert pathologists were asked to review 70 consultation level cases with Spitzoid features, once with limited clinical information and again with additional genomic information. There was an improvement in overall agreement with additional genomic information. Most significantly, there was increase in agreement of the diagnosis of conventional melanoma from moderate (kappa=0.470, SE=0.0105) to substantial (kappa=0.645, SE=0.0143) as measured by an average Cohen kappa. Clinical follow-up was available in all 70 cases which substantiated that the improved agreement was clinically significant. Among 3 patients with distant metastatic disease, there was a highly significant increase in diagnostic recognition of the cases as conventional melanoma with genomics (P<0.005). In one case, none of 20 pathologists recognized a tumor with BRAF and TERT promoter mutations associated with fatal outcome as a conventional melanoma when only limited clinical information was provided, whereas 60% of pathologists correctly diagnosed this case when genomic information was also available. There was also a significant improvement in agreement of which lesions should be classified in the Spitz category/WHO Pathway from an average Cohen kappa of 0.360 (SE=0.00921) to 0.607 (SE=0.0232) with genomics.
- Find related publications in this database (Keywords)
- genomics
- next-generation sequencing
- Spitz neoplasms
- melanoma
- consensus